Business context and reporting period
The supplied filing is LRAD Corporation’s unaudited Form 10-Q for the quarter and six months ended March 31, 2012. The request metadata names Genasys Inc.; the filing itself identifies the registrant as LRAD Corporation, so the entity match should be verified. LRAD designs and sells directed-sound products, primarily for military, government, maritime and commercial security applications.
Financial performance
| Metric | Three months ended March 31, 2012 | Six months ended March 31, 2012 |
|---|---|---|
| Revenue | $2.40 million | $6.01 million |
| Gross profit / margin | $1.32 million / 54.9% | $3.07 million / 51.0% |
| Operating income (loss) | $(306,000) | $5,000 |
| Net income (loss) | $(292,000) | $22,000 |
| Operating cash flow | Not presented for the quarter | $40,000 |
- For the six months, cash and cash equivalents were $13.88 million; restricted cash was $645,656. Current assets exceeded current liabilities by $19.43 million at March 31, 2012.
- Total liabilities were $1.30 million, including $323,687 of noncurrent liabilities. The company reported no debt.
- Six-month investing cash outflow was $23,174; there were no financing cash flows.
Changes versus prior comparable periods
- Quarterly revenue fell 84.5% from $15.50 million; six-month revenue fell 66.0% from $17.71 million. Management attributed the declines chiefly to a $12.1 million foreign military order delivered in the prior-year period that did not recur.
- Quarterly gross margin declined from 70.1% to 54.9%; six-month gross margin declined from 67.0% to 51.0%. Management cited the prior order’s unusually favorable margins and production-volume effects, as well as product and channel mix.
- The quarter shifted from $5.70 million net income to a $292,000 loss. Six-month net income declined from $5.35 million to $22,000.
- Six-month operating cash flow declined from $1.46 million to $40,000, despite a $2.96 million reduction in accounts receivable; cash uses included lower accrued liabilities and accounts payable and increased inventory.
Outlook, risks and other notable items
- Management expects uneven quarterly revenue and said military budget constraints and uncertainty in U.S. and international markets could delay orders or constrain growth. It believes current cash can fund operations for the next 12 months under planned spending and operating assumptions, but cautions that additional capital might be needed and may not be available on acceptable terms.
- Management reported positive market response to the expanding LRAD-X line and a first order for its LRAD 360-degree product. It expected fiscal 2012 research and development spending to be comparable to the prior year.
- Two customers represented 22% and 10% of quarterly revenue; two customers represented 14% and 16% of six-month revenue. Two customers accounted for 46% and 11% of accounts receivable at quarter-end.
- Approximately $10.8 million of cash and cash-equivalent deposits exceeded FDIC insurance limits. Restricted cash supports bank guarantees related to a customer contract.
- Outstanding warrants cover 1,627,945 shares at $2.67 per share through February 2016. Registration-rights provisions could require liquidated damages up to $869,323.
- The company recorded a full valuation allowance against deferred tax assets and expected a zero annual effective tax rate. It reported no pending material legal proceedings. Disclosure controls were concluded effective as of March 31, 2012.
Important facts for investors to verify
- Confirm that this LRAD Corporation filing is the intended filing for the Genasys Inc. request.
- Assess how much of the revenue and margin decline reflects the nonrecurrence of the prior-year military order, and the timing and size of future orders.
- Review customer concentration, receivable collection timing, inventory levels and restricted-cash availability.
- Verify the assumptions supporting management’s 12-month liquidity assessment and monitor any potential need for additional financing.
- Review warrant dilution and the potential registration-rights damages exposure.